Ana Poveda

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Trypanosoma Cruzi

Molecular Docking

Oxide Nanoparticles

Top Venues

Pathogens (Basel, Switzerland)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Javier Santamaría-Aguirre, Daniela Jacho, Miguel Ángel Méndez, Ana Poveda, Javier Carrión, Monica L Fanarraga
Solid Lipid Nanoparticles Enhancing the Leishmanicidal Activity of Delamanid. Pharmaceutics 16 (1) (2023)
Sara M Robledo, Silvia Pérez-Silanes, Celia Fernández-Rubio, Ana Poveda, Lianet Monzote-Fidalgo, Víctor M González, Paloma Alonso-Collado, Javier Carrión
Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease. Pathogens (Basel, Switzerland) 12 (7) (2023)
Javier Santamaría-Aguirre, Daniela Jacho, Miguel Ángel Méndez, Ana Poveda, Javier Carrión, Monica L Fanarraga
Solid Lipid Nanoparticles Enhancing the Leishmanicidal Activity of Delamanid. Pharmaceutics 16 (1) (2023)
Javier Santamaría-Aguirre, Daniela Jacho, Miguel Ángel Méndez, Ana Poveda, Javier Carrión, Monica L Fanarraga
Solid Lipid Nanoparticles Enhancing the Leishmanicidal Activity of Delamanid. Pharmaceutics 16 (1) (2023)
Manuel Alejandro Coba-Males, Pablo Medrano-Vizcaíno, Sandra Enríquez, David Brito-Zapata, Sarah Martin-Solano, Sofía Ocaña-Mayorga, Gabriel Alberto Carrillo-Bilbao, Wilmer Narváez, Jaime Antonio Salas, Jazzmín Arrivillaga-Henríquez, Manuela González-Suárez, Ana Poveda
From roads to biobanks: Roadkill animals as a valuable source of genetic data. PloS one 18 (12) (2023)
Olalla Barreiro-Costa, Gabriela Morales-Noboa, Patricio Rojas-Silva, Eliana Lara-Barba, Javier Santamaría-Aguirre, Natalia Bailon-Moscoso, Juan Carlos Romero-Benavides, Ana Herrera, Cristina Cueva, Lenin Ron-Garrido, Ana Poveda, Jorge Heredia-Moya
Synthesis and Evaluation of Biological Activities of Bis(spiropyrazolone)cyclopropanes: A Potential Application against Leishmaniasis. Molecules (Basel, Switzerland) 26 (16) (2021)